Catherine Bollard, MBChB, MD, FRACP, FRCPA, Children’s National Health System, Washington, DC
Expert in T-cell therapies for NHL
Best podcasts with Catherine Bollard, MBChB, MD, FRACP, FRCPA, Children’s National Health System, Washington, DC
Ranked by the Snipd community
Nov 30, 2022 • 18min
iwNHL Session IV: T-cell therapies for NHL: CAR-T therapies & third-party EBV T-cells
Catherine Bollard and Jeremy Abramson discuss T-cell therapies for NHL, including CAR-T therapies and third-party EBV T-cells. They explore real-world data on CD19-directed CAR-Ts and the potential of CD30, CD20, and CD5-directed CAR-Ts in T-cell lymphomas. Topics include safety and efficacy comparisons of different therapies, prescribing patterns, advancements in T-cell therapies, overcoming challenges in CAR-T development, and targeting antigens beyond CD19.
